Development and validation of a multimodal deep learning framework for vascular cognitive impairment diagnosis
Cerebrovascular disease (CVD) is the second leading cause of dementia worldwide. The accurate detection of vascular cognitive impairment (VCI) in CVD patients remains an unresolved challenge. We collected the clinical non-imaging data and neuroimaging data from 307 subjects with CVD. Using these data, we developed a multimodal deep learning framework that combined the vision transformer and extreme gradient boosting algorithms. The final hybrid model within the framework included only two neuroimaging features and six clinical features, demonstrating robust performance across both internal and external datasets. Furthermore, the diagnostic performance of our model on a specific dataset was demonstrated to be comparable to that of expert clinicians. Notably, our model can identify the brain regions and clinical features that significantly contribute to the VCI diagnosis, thereby enhancing transparency and interpretability. We developed an accurate and explainable clinical decision support tool to identify the presence of VCI in patients with CVD.
Authors
- Juan Xu (ORCID: https://orcid.org/0000-0002-6626-1700)
- Xiaoxiang Peng (ORCID: https://orcid.org/0000-0001-6339-0462)
- Chu He
- Jiu Jiang
- Tianrui Li (ORCID: https://orcid.org/0000-0001-7780-104X)
- Haoying He (ORCID: https://orcid.org/0009-0003-4575-0227)
- Fan Fan (ORCID: https://orcid.org/0000-0003-3986-5303)
- Dong Sun (ORCID: https://orcid.org/0000-0003-3945-4037)
- Ran Zhang (ORCID: https://orcid.org/0000-0003-3376-6945)
- Ming Lei (ORCID: https://orcid.org/0000-0001-9818-3586)
- Junjian Zhang (ORCID: https://orcid.org/0000-0002-4557-5137)
- Zhipeng Xu (ORCID: https://orcid.org/0000-0002-6661-5572)
- Sisi Peng
- Hao Song (ORCID: https://orcid.org/0009-0003-6158-0408)
- Jing Cao (ORCID: https://orcid.org/0000-0003-3124-4780)
Institutions
- Wuhan University (CN)
- Shanghai Ship and Shipping Research Institute (CN)
- Wuhan Business University (CN)
- Zhongnan Hospital of Wuhan University (CN)
- Hubei Zhongshan Hospital (CN)
- Yangtze River Pharmaceutical Group (China) (CN)
Publication Details
- Journal
- iScience
- Published
- 2024-09-13
- DOI
- https://doi.org/10.1016/j.isci.2024.110945
- Citations
- 9
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- article
- Field-Weighted Citation Impact
- 3.48
Funders
- National Natural Science Foundation of China